Live Breaking News & Updates on News Ratings For Biocryst Pharmaceuticals Daily|Page 1

Stay updated with breaking news from News ratings for biocryst pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Oracle Investment Management Inc. Sells 19,964 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Oracle Investment Management Inc. reduced its holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 3.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 535,558 shares of the biotechnology company’s stock after selling 19,964 shares during the period. […] ....

Alang Levin , Stevenk Galson , Exchange Commission , Securities Exchange Commission , News Ratings For Biocryst Pharmaceuticals Daily , Quarter For Biocryst Pharmaceuticals , Deerfield Management Companylp Series , Vanguard Group Inc , Needham Company , Oracle Investment Management Inc , Rafferty Asset Management , Norges Bank , Biocryst Pharmaceuticals , Biocryst Pharmaceuticals Price Performance , Biocryst Pharmaceuticals Inc , Oracle Investment Management , Free Report , Cryst Pharmaceuticals , Investment Management , Asset Management , Director Alan , Director Steven , Get Free Report , Visit Holdingschannel , Biocryst Pharmaceuticals Daily ,

Avoro Capital Advisors LLC Increases Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Avoro Capital Advisors LLC lifted its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,050,000 shares of the biotechnology company’s stock after purchasing an additional 1,500,000 shares during […] ....

Recursos Ltda , Stevenk Galson , Nancyj Hutson , Quarter For Biocryst Pharmaceuticals , Exchange Commission , Pinnacle Wealth Planning Services Inc , Avoro Capital Advisors , Biocryst Pharmaceuticals Inc , News Ratings For Biocryst Pharmaceuticals Daily , Biocryst Pharmaceuticals , Securities Exchange Commission , Biocryst Pharmaceuticals Stock Performance , Biocryst Pharmaceuticals Company Profile , Needham Company , Capstone Investment Advisors , Tower Research Capital , Free Report , Cryst Pharmaceuticals , Capital Advisors , Research Capital , Gestao De Recursos , Investment Advisors , Pinnacle Wealth Planning Services , Get Free Report , Director Steven , Director Nancy ,

Avoro Capital Advisors LLC Increases Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Avoro Capital Advisors LLC lifted its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,050,000 shares of the biotechnology company’s stock after purchasing an additional 1,500,000 shares during […] ....

Recursos Ltda , Nancyj Hutson , Stevenk Galson , Biocryst Pharmaceuticals , Biocryst Pharmaceuticals Stock Performance , Securities Exchange Commission , Biocryst Pharmaceuticals Company Profile , Needham Company , Capstone Investment Advisors , Tower Research Capital , Quarter For Biocryst Pharmaceuticals , Pinnacle Wealth Planning Services Inc , Exchange Commission , Avoro Capital Advisors , News Ratings For Biocryst Pharmaceuticals Daily , Biocryst Pharmaceuticals Inc , Free Report , Cryst Pharmaceuticals , Capital Advisors , Research Capital , Gestao De Recursos , Investment Advisors , Pinnacle Wealth Planning Services , Get Free Report , Director Steven , Director Nancy ,

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Director Buys $49,995.96 in Stock

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Director Buys $49,995.96 in Stock
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Alang Levin , Recursos Ltda , Biocryst Pharmaceuticals Inc , News Ratings For Biocryst Pharmaceuticals Daily , Tower Research Capital , Biocryst Pharmaceuticals Trading Down , Securities Exchange Commission , Institutional Trading Of Biocryst Pharmaceuticals , Biocryst Pharmaceuticals , Needham Company , Get Free Report , Director Alan , Exchange Commission , Cryst Pharmaceuticals Trading Down , Cryst Pharmaceuticals , Eight Capital , Research Capital , Gestao De Recursos , Biocryst Pharmaceuticals Daily ,

Analysts Set BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Price Target at $14.00

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) has received a consensus recommendation of “Buy” from the seven analysts that are currently covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued a report on the stock in the last […] ....

Nancyj Hutson , Stevenk Galson , Insider Transactions At Biocryst Pharmaceuticals , Institutional Trading Of Biocryst Pharmaceuticals , Tower Research Capital , Biocryst Pharmaceuticals Company Profile , Biocryst Pharmaceuticals , Biocryst Pharmaceuticals Stock Down , Biocryst Pharmaceuticals Inc , Fifth Third Bancorp , Analyst Recommendations For Biocryst Pharmaceuticals , Securities Exchange Commission , Third Bancorp , News Ratings For Biocryst Pharmaceuticals Daily , Needham Company , Get Free Report , Director Steven , Director Nancy , Exchange Commission , Eight Capital , Research Capital , Cryst Pharmaceuticals Stock Down , Cryst Pharmaceuticals , Get Free , Biocryst Pharmaceuticals Daily ,